UroGen Pharma Ltd. (URGN) rose 5.57% or 2.51 to $47.55. It is close to 49252 shares traded, which is 73.33% compare to the average total volume 67167. The market cap of URGN is $753.82 million. The year to date change is 22.14%. The 52 week price range is from $25.56 to $69.57. Price of URGN have changed 2.60% during last week. It have changed 4.77% over last month, -18.45% over last 3 months, -15.40% over last 6 months and 40.18% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for URGN is 45.72. It is -3.85% below current price. The 200-day Moving Averages for URGN is 50.38. It is 5.95% above current price. The 52-week High is 69.57. It is 46.31% from the current price. The 52-week Low is 25.56. It is -46.25% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of URGN is 5.14 on 2018-08-31. Short % to float is 2.23%. There are some statistics of URGN. It is has market cap $753.82 million. The share outstanding is 15.85 million. The average volume is 67167. The revenue is 7.81M. The gross profit is 7.52M. The percent of top 15 Institution holding is 47.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of URGN is -44.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of URGN is -41.68%.